Skip to main content
Log in

Stimulatory Effects of KPR-A148 on Osteoblast Differentiation and Bone Regeneration

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Background:

Xanthine derivatives have been used to treat a variety of medical conditions including respiratory disease and neural degeneration. However, few studies have reported their effects on bone regeneration. Therefore, we investigated the effects of KPR-A148, a synthetic xanthine derivative on osteoblast differentiation in vitro and bone regeneration in vivo.

Methods:

The cytotoxicity of KPR-A148 was evaluated using MC3T3-E1 cells by the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltertrazolium bromide assay. The effects of KPR-A148 on osteoblast differentiation were examined by alkaline phosphatase staining, Alizarin red S staining, and real-time PCR of osteoblast differentiation marker genes. To investigate the effects of KPR-A148 on in vivo bone regeneration, a KPR-A148-containing collagen sponge was implanted into a mouse calvarial defect and KPR-A148 was injected twice, weekly. Bone regeneration was evaluated quantitatively by micro-CT and qualitatively by hematoxylin and eosin, as well as Masson’s Trichrome staining.

Results:

KPR-A148 did not show toxicity in the MC3T3-E1 cells and promoted osteoblast differentiation in a concentration-dependent manner. 10 μM of KPR-A148 showed the most significant effect on alkaline phospatase staining and matrix mineralization. KPR-A148 increased the expression of osteoblast marker genes in both the early and late stages of differentiation. In addition, KPR-A148 significantly induced new bone formation in the calvarial defect model.

Conclusion:

These results demonstrate that KPR-A148 strongly induces osteoblast differentiation and new bone formation. Therefore, it could be used as a potential therapeutic agent for regenerating bone following its destruction by disease or trauma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Shivalkar S, Singh S. Solid freeform techniques application in bone tissue engineering for scaffold fabrication. Tissue Eng Regen Med. 2017;14:187–200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kashte S, Jaiswal AK, Kadam S. Artificial bone via bone tissue engineering: current scenario and challenges. Tissue Eng Regen Med. 2017;14:1–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Li Y, Chen SK, Li L, Qin L, Wang XL, Lai YX. Bone defect animal models for testing efficacy of bone substitute biomaterials. J Orthop Translat. 2015;3:95–104.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, Luyten FP, Picart C. Bone regeneration strategies: engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials. 2018;180:143–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chamieh F, Collignon AM, Coyac BR, Lesieur J, Ribes S, Sadoine J, et al. Accelerated craniofacial bone regeneration through dense collagen gel scaffolds seeded with dental pulp stem cells. Sci Rep. 2016;6:38814.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tollemar V, Collier ZJ, Mohammed MK, Lee MJ, Ameer GA, Reid RR. Stem cells, growth factors and scaffolds in craniofacial regenerative medicine. Genes Dis. 2016;3:56–71.

    Article  CAS  PubMed  Google Scholar 

  7. Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov. 2008;92:161–8.

    Article  PubMed  Google Scholar 

  8. Pountos I, Panteli M, Lampropoulos A, Jones E, Calori GM, Giannoudis PV. The role of peptides in bone healing and regeneration: a systematic review. BMC Med. 2016;14:103.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Aravamudhan A, Ramos DM, Nip J, Subramanian A, James R, Harmon MD, et al. Osteoinductive small molecules: growth factor alternatives for bone tissue engineering. Curr Pharm Des. 2013;19:3420–8.

    Article  CAS  PubMed  Google Scholar 

  10. Balmayor ER. Targeted delivery as key for the success of small osteoinductive molecules. Adv Drug Deliv Rev. 2015;94:13–27.

    Article  CAS  PubMed  Google Scholar 

  11. Kim JA, Yun HS, Choi YA, Kim JE, Choi SY, Kwon TG, et al. Magnesium phosphate ceramics incorporating a novel indene compound promote osteoblast differentiation in vitro and bone regeneration in vivo. Biomaterials. 2018;157:51–61.

    Article  CAS  PubMed  Google Scholar 

  12. Rosemeyer H. The chemodiversity of purine as a constituent of natural products. Chem Biodivers. 2004;1:361–401.

    Article  CAS  PubMed  Google Scholar 

  13. Müller CE, Jacobson KA. Xanthines as Adenosine Receptor Antagonists. In: Fredholm BB, editor. Methylxanthines. Handbook of Experimental Pharmacology, vol 200. Berlin: Springer; 2018. p. 151–99.

    Google Scholar 

  14. Cushley MJ, Holgate ST. Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax. 1985;40:176–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17:139–70.

    Article  CAS  PubMed  Google Scholar 

  16. Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Caffeine therapy in preterm infants. World J Clin Pediatr. 2015;4:81–93.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188:901–6.

    Article  CAS  PubMed  Google Scholar 

  18. Rother M, Erkinjuntti T, Roessner M, Kittner B, Marcusson J, Karlsson I. Propentofylline in the treatment of Alzheimer’s disease and vascular dementia: a review of phase III trials. Dement Geriatr Cogn Disord. 1998;9 Suppl 1:36–43.

    Article  CAS  PubMed  Google Scholar 

  19. Clough BH, Ylostalo J, Browder E, McNeill EP, Bartosh TJ, Rawls HR, et al. Theobromine upregulates osteogenesis by human mesenchymal stem cells in vitro and accelerates bone development in rats. Calcif Tissue Int. 2017;100:298–310.

    Article  CAS  PubMed  Google Scholar 

  20. Pal S, Porwal K, Khanna K, Gautam MK, Malik MY, Rashid M, et al. Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: a comparative study with human parathyroid hormone. Bone. 2019;123:28–38.

    Article  CAS  PubMed  Google Scholar 

  21. Vashghani Farahani MM, Ahadi R, Abdollahifar M, Bayat M. The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model. Lab Anim Res. 2017;33:15–23.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kinoshita T, Kobayashi S, Ebara S, Yoshimura Y, Horiuchi H, Tsutsumimoto T, et al. Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice. Bone. 2000;27:811–7.

    Article  CAS  PubMed  Google Scholar 

  23. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol. 1983;96:191–8.

    Article  CAS  PubMed  Google Scholar 

  24. Lee D, Lee S, Liu KH, Bae JS, Baek DJ, Lee T. Solid-phase synthesis of 1,3,7,8-tetrasubstituted xanthine derivatives on traceless solid support. ACS Comb Sci. 2016;18:70–4.

    Article  CAS  PubMed  Google Scholar 

  25. Beck GR Jr, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A. 2000;97:8352–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Boswell-Smith V, Cazzola M, Page CP. Are phosphodiesterase 4 inhibitors just more theophylline? J Allergy Clin Immunol. 2006;117:1237–43.

    Article  CAS  PubMed  Google Scholar 

  27. Vignoli JA, Bassoli DG, Benassi MT. Antioxidant activity, polyphenols, caffeine and melanoidins in soluble coffee: the influence of processing conditions and raw material. Food Chem. 2011;124:863–8.

    Article  CAS  Google Scholar 

  28. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun. 2003;309:689–94.

    Article  CAS  PubMed  Google Scholar 

  29. Liu T, Gao Y, Sakamoto K, Minamizato T, Furukawa K, Tsukazaki T, et al. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J Cell Physiol. 2007;211:728–35.

    Article  CAS  PubMed  Google Scholar 

  30. Kim JA, Choi YA, Yun HS, Bae YC, Shin HI, Park EK. Extracellular calcium-binding peptide-modified ceramics stimulate regeneration of calvarial bone defects. Tissue Eng Regen Med. 2016;13:57–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MSIT) (NRF-2017M3A9E4047244).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eui Kyun Park.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

All animal experiments were approved by the committee on the care and use of animals in research at Kyungpook National University, South Korea, and conducted in accordance with the guidelines for the Care and Use of Laboratory Animals (2017-0074).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, S., Kim, J.A., Lee, T. et al. Stimulatory Effects of KPR-A148 on Osteoblast Differentiation and Bone Regeneration. Tissue Eng Regen Med 16, 405–413 (2019). https://doi.org/10.1007/s13770-019-00200-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-019-00200-3

Keywords

Navigation